Why Zevra Therapeutics Stock Zoomed 21% Higher Today
It also posted 44% net revenue growth for the period. Both headline figures crushed the consensus analyst estimates.
Open original sourceLoading market dashboard
It also posted 44% net revenue growth for the period. Both headline figures crushed the consensus analyst estimates.
Open original source